• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthChina

Biotech Giant Thermo Fisher Stops Selling DNA Sequencers in Repressive Chinese Region

By
David Meyer
David Meyer
Down Arrow Button Icon
By
David Meyer
David Meyer
Down Arrow Button Icon
February 21, 2019, 7:02 AM ET
Video Poster

The Massachusetts biotechnology giant Thermo Fisher Scientific has decided to stop selling genetic sequencing equipment in the Chinese region of Xinjiang, where the authorities have for years been persecuting the local Muslim population.

Xinjiang is the main home of China’s Uighur minority—a Turkic group that is primarily Muslim. As many as a million Uighurs have been interned in “re-education” camps that the authorities say are necessary to combat separatism and religious extremism. Heavy surveillance is commonplace in the oil-rich region, with cameras everywhere and people forced to install spyware on their smartphones.

Part of the surveillance effort is the collection not only of biometric data such as iris scans and fingerprints, but also DNA, as part of a health program. A database is being compiled of every person’s genetic information, not just that of criminal suspects, and it’s not at all clear that informed consent is involved.

Human Rights Watch said in late 2017 that Thermo Fisher was supplying some of the DNA sequencers for this project. The NGO confronted the company, only to be told that “it is not possible for us to monitor the use or application of all products we manufactured.”

Since then, however, U.S. politicians got involved, in particular Florida Sen. Marco Rubio, who pushed for a crackdown on the use of American technology in human rights violations by the Chinese authorities.

On Wednesday, the Wall Street Journal reported Thermo Fisher as saying it had taken account of “fact-specific assessments,” and that it recognizes “the importance of considering how our products and services are used—or may be used—by our customers.”

The manufacturers of DNA sequencers are mostly based in the U.S., with a couple coming from Europe and one notable new entrant to the market—BGI—being Chinese. BGI was reportedly set up with state support.

On a related note, the World Health Organization last week announced a new committee that will write guidelines for human genome editing. The decision comes after Chinese scientist He Jiankui last year claimed to have used DNA editing to produce HIV-resistant twins—the first babies in the world to have edited genes.

About the Author
By David Meyer
LinkedIn icon
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Susan Blumenthal
AICancer
Meet the American spies who helped mammograms save more lives
By Erik GermanFebruary 15, 2026
5 hours ago
HealthDietary Supplements
5 Best Nootropics of 2026: Expert Reviewed Supplements
By Christina SnyderFebruary 13, 2026
2 days ago
Big TechGen Z
Analog-obsessed Gen Zers are buying $40 app blockers to limit their social media use and take a break from the ‘slot machine in your pocket’
By Marco Quiroz-GutierrezFebruary 13, 2026
2 days ago
Leesa Sapira Chill
Healthmattresses
Presidents Day Mattress Sales 2026: Find Deals on the Best Sleep Brands
By Christina SnyderFebruary 13, 2026
2 days ago
dog
CommentaryAnimals
You love your dog too much. Blame the broken American Dream and loss of purpose since the pandemic
By Margret Grebowicz and The ConversationFebruary 13, 2026
2 days ago
Healthsleep
Leesa Mattress Review (2026): Rigorously Tested
By Christina SnyderFebruary 12, 2026
3 days ago

Most Popular

placeholder alt text
AI
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI
By Jake AngeloFebruary 13, 2026
2 days ago
placeholder alt text
Success
MacKenzie Scott says her college roommate loaned her $1,000 so she wouldn't have to drop out—and is now inspiring her to give away billions
By Sydney LakeFebruary 14, 2026
1 day ago
placeholder alt text
Big Tech
Analog-obsessed Gen Zers are buying $40 app blockers to limit their social media use and take a break from the ‘slot machine in your pocket’
By Marco Quiroz-GutierrezFebruary 13, 2026
2 days ago
placeholder alt text
Future of Work
Malcolm Gladwell tells young people if they want a STEM degree, 'don’t go to Harvard.' You may end up at the bottom of your class and drop out
By Sasha RogelbergFebruary 14, 2026
1 day ago
placeholder alt text
Economy
A U.S. 'debt spiral' could start soon as the interest rate on government borrowing is poised to exceed economic growth, budget watchdog says
By Jason MaFebruary 14, 2026
24 hours ago
placeholder alt text
Personal Finance
Current price of gold as of February 13, 2026
By Danny BakstFebruary 13, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.